Millennium Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-239,414
| Closed | -$128K | – | 6626 |
|
|
2024
Q4 | $128K | Sell |
239,414
-243,093
| -50% | -$169K | ﹤0.01% | 5429 |
|
|
2024
Q3 | $849K | Sell |
482,507
-236,073
| -33% | -$330K | ﹤0.01% | 4404 |
|
|
2024
Q2 | $841K | Buy |
+718,580
| New | +$1.8M | ﹤0.01% | 4223 |
|
|
2024
Q1 | – | Sell |
-25,663
| Closed | -$249K | – | 6782 |
|
|
2023
Q4 | $279K | Buy |
+25,663
| New | +$192K | ﹤0.01% | 4999 |
|
|
2023
Q3 | – | Sell |
-13,240
| Closed | -$144K | – | 6711 |
|
|
2023
Q2 | $144K | Sell |
13,240
-917,526
| -99% | -$7.86M | ﹤0.01% | 5238 |
|
|
2023
Q1 | $6.42M | Sell |
930,766
-151,993
| -14% | -$953K | ﹤0.01% | 2375 |
|
|
2022
Q4 | $4.31M | Buy |
1,082,759
+872,782
| +416% | +$4.29M | ﹤0.01% | 2941 |
|
|
2022
Q3 | $1.4M | Sell |
209,977
-174,094
| -45% | -$1.07M | ﹤0.01% | 4057 |
|
|
2022
Q2 | $1.86M | Buy |
+384,071
| New | +$2.34M | ﹤0.01% | 3777 |
|
|
2021
Q2 | – | Sell |
-45,339
| Closed | -$702K | – | 7271 |
|
|
2021
Q1 | $702K | Buy |
45,339
+8,642
| +24% | +$125K | ﹤0.01% | 4540 |
|
|
2020
Q4 | $448K | Sell |
36,697
-310,295
| -89% | -$4.33M | ﹤0.01% | 4283 |
|
|
2020
Q3 | $4.46K | Buy |
346,992
+113,453
| +49% | +$979K | 0.01% | 1945 |
|
|
2020
Q2 | $2.37M | Buy |
+233,539
| New | +$2.15M | ﹤0.01% | 2399 |
|
|
2020
Q1 | – | Sell |
-15,889
| Closed | -$137K | – | 4653 |
|
|
2019
Q4 | $137K | Buy |
+15,889
| New | +$89.2K | ﹤0.01% | 3959 |
|
|
2019
Q1 | – | Sell |
-78,961
| Closed | -$906K | – | 4411 |
|
|
2018
Q4 | $906K | Buy |
78,961
+34,208
| +76% | +$692K | ﹤0.01% | 2631 |
|
|
2018
Q3 | $1.79M | Buy |
44,753
+5,520
| +14% | +$157K | ﹤0.01% | 2510 |
|
|
2018
Q2 | $1.11M | Sell |
39,233
-105,552
| -73% | -$2.34M | ﹤0.01% | 2773 |
|
|
2018
Q1 | $2.21M | Sell |
144,785
-84,120
| -37% | -$2M | ﹤0.01% | 2254 |
|
|
2017
Q4 | $7.47M | Buy |
228,905
+11,923
| +5% | +$321K | 0.01% | 1516 |
|
|
2017
Q3 | $5.09M | Buy |
+216,982
| New | +$2.43M | 0.01% | 1660 |
|
|
2014
Q4 | – | Sell |
-4,516
| Closed | -$117K | – | 4349 |
|
|
2014
Q3 | $117K | Buy |
+4,516
| New | +$140K | ﹤0.01% | 3523 |
|
Millennium Management's MRNS Position: Q1 2025 in Review
Millennium Management sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 239,414 shares — an estimated $128K sold.
Millennium Management first reported a position in MRNS in Q3 2014 and held it in 21 quarters. The position peaked at $7.47M in Q4 2017. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.
- Millennium Management reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
- Millennium Management sold 239,414 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $128K.
- Millennium Management first reported a position in Marinus Pharmaceuticals, Inc in Q3 2014 and held it in 21 quarters.
- Millennium Management's Marinus Pharmaceuticals, Inc position peaked at $7.47M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.
Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.